HSP70-2 (HSPA1B) Is Associated with Noncognitive Symptoms in Late-Onset Alzheimer's Disease

Journal of Geriatric Psychiatry and Neurology

Volumn 16, Issue 3, 2003, Pages 146-150

  Clarimón, Jordi ^a   Bertranpetit, Jaume ^a   Boada, Mercè ^b   Tàrraga, Llufs ^b   Comas, David ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b Fund ACE IC Neurociencies Apl   (Spain)

Author keywords

Alzheimer's disease; HSP70 gene; Noncognitive symptomatology

Indexed keywords

HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 2; HEAT SHOCK PROTEIN A1B; UNCLASSIFIED DRUG;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CELL PROTECTION; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHIATRY; NUCLEOTIDE SEQUENCE; ONSET AGE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RATING SCALE; SCORING SYSTEM; SYMPTOM;

AGE FACTORS; AGED; ALZHEIMER DISEASE; COGNITION; FEMALE; GENE DELETION; GENOTYPE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; OXIDATIVE STRESS; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0242428468     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/0891988703256051     Document Type: Article

References (43)

1. Ballard C, Lowery K, Powell I, et al. Impact of behavioral and psychological symptoms of dementia on caregivers. Int Psychogeriatr 2000; 12:93-105.
2. Balesteri L, Grossberg A, Grossberg GT. Behavioral and psychological symptoms of dementia as a risk factor for nursing home placement. Int Psychogeriatr 2000; 12:59-63.
3. Beeri MS, Werner P, Adar Z, et al. Economic cost of Alzheimer disease in Israel. Alzheimer Dis Assoc Disord 2002; 16:73-80.
4. Petry S, Cummings JL, Hill MA, Shapira J. Personality alterations in dementia of the Alzheimer type. Arch Neurol 1988; 45:1187-1190.
5. Rubin EH, Kinscherf DA. Psychopathology of very mild dementia of the Alzheimer type. Am J Psychiatry 1989; 146:1017-1021.
6. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996; 46:130-135.
7. Murphy GM, Taylor J, Tinklenberg JR, Yesavage JA. The apolipoprotein E epsilon 4 is associated with increased behavioral disturbance in Alzheimer's disease. Am J Geriatr Psychiatry 1997; 5:88-89.
8. Ramachandran G, Marder K, Tang M, et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996; 47:256-259.
9. Weiner MF, Vega G, Risser RC, et al. Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry 1999; 45:633-638.
10. Forsell Y, Basun H, Corder EH, et al. Psychotic symptoms and apolipoprotein E genotypes in an elderly population. Biol Psychiatry 1998; 44:139-140.
11. Harwood DG, Barker WW, Ownby RL, et al. Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry 1999; 7:119-123.
12. Hirono N, Mori E, Yasuda M, et al. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1999; 11:66-70.
13. Holmes C, Levy R, McLoughin DM, et al. Apolipoprotein E: noncognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61:580-583.
14. Levy ML, Cummings JL, Fairbanks LA, et al. Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biol Psychiatry 1999; 45:422-425.
15. Lopez OL, Kamboh MI, Becker JT, et al. The apolipoprotein E ε4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease. Neurology 1997; 49:794-797.
16. Lyketsos CG, Baker L, Warren A, et al. Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype. J Neuropsychiatry Clin Neurosci 1997; 9:64-67.
17. Holmes C, Arranz MJ, Powell JF, et al. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum Mol Genet 1998; 7:1507-1509.
18. Sweet RA, Nimgaonkar VL, Kamboh MI, et al. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. Arch Neurol 1998; 55:1335-1340.
19. Sweet RA, Nimgaonkar VL, Devlin B, et al. Increased familial risk of the psychotic phenotype of Alzheimer disease. Neurology 2002; 58:907-911.
20. Papolla MA, Sos M, Omar RA, Sambamurti K. The heat shock/oxidative stress connection: relevance to Alzheimer disease. Mol Chem Neuropathol 1996; 28:21-34.
21. Rottkamp CA, Nunomura A, Raina AK, et al. Oxidative stress, antioxidants, and Alzheimer disease. Alzheimer Dis Assoc Disord 2000; 14:S62-S66.
22. Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide. Trends Mol Med 2001; 7:548-553.
23. Beckmann RP, Mizzen LE, Welch WJ. Interaction of Hsp 70 with newly synthesized proteins: implication for protein folding and assembly. Science 1990; 248:850-854.
24. Gething MJ, Sambrook J. Protein folding in the cell. Nature 1992; 355:33-45.
25. Hartl FU. Molecular chaperones in cellular protein folding. Nature 1996; 381:571-579.
26. Salvotinek AM, Biesecker LG. Unfolding the role of chaperones and chaperonins in human disease. Trends Genet 2001; 17:528-535.
27. McGeer PL, Klegeris A, Walker DG, et al. Pathological proteins in senile plaques. Tohoku J Exp Med 1994; 174:269-277.
28. Kirby BA, Merril CR, Ghanbari H, Wallace WC. Heat shock proteins protect against stress-related phosphorylation of tau in neuronal PC12 cells that have acquired thermotolerance. J Neurosci 1994; 14:5687-5693.
29. Harrison PJ, Procter AW, Exworthy T, et al. Heat shock protein (hsx70) mRNA expression in human brain: effects of neurodegenerative disease and agonal state. Neuropathol Appl Neurobiol 1993; 19:10-21.
30. Hamos JE, Oblas B, Pulaski-Salo D, et al. Expression of heat shock proteins in Alzheimer's disease. Neurology 1991; 41:345-650.
31. Yoo BC, Seidl R, Cairns N, Lubec G. Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease. J Neural Transm 1999; 57:315-322.
32. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52:998-1007.
33. Kim JJ, Lee SJ, Toh KY, et al. Identification of antibodies to heat shock proteins 90 kDa and 70 kDa in patients with schizophrenia. Schizophr Res 2001; 52:127-135.
34. Schwarz MJ, Riedel M, Gruber R, et al. Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease. Am J Psychiatry 1999; 156:1103-1104.
35. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
36. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44:2308-2314.
37. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 1975; 12:189-198.
38. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Woodbury, NY: Cold Spring Harbor Laboratory Press, 1989.
39. Dressel R, Günther E. A pentanucleotide tandem duplication polymorphism in the 3′ untranslated region of the HLA-linked heat-shock protein 70-2 (HSP70-2) gene. Hum Genet 1994; 94:585-586.
40. Petersen RB, Lindquist S. Regulation of HSP70 synthesis by messenger RNA degradation. Cell Regul 1989; 1:135-149.
41. Moseley PL, Wallen ES, McCafferty JD, et al. Heat stress regulates the human 70-kDa heat-shock gene through the 3′-untranslated region. Am J Physiol 1993; 264:L533-L537.
42. Schwerin M, Maak S, Hagendorf A, et al. A 3′-UTR variant of the inducible porcine hsp70.2 gene affects mRNA stability. Biochim Biophys Acta 2002; 1578:90-94.
43. Johnson G, Refolo LM, Merril CR, Wallace W. Altered expression and phosphorylation of amyloid precursor protein in heat shocked neuronal PC12 cells. Brain Res Mol Brain Res 1993; 19:140-148.